Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated:  11/13/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated: 11/13/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated:  11/13/2015
Wake Forest Medical Center
mi
from
Winston Salem, NC
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated: 11/13/2015
Wake Forest Medical Center
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated:  11/13/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated: 11/13/2015
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated:  11/13/2015
University of Pittsburg
mi
from
Pittsburg, PA
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated: 11/13/2015
University of Pittsburg
mi
from
Pittsburg, PA
Click here to add this to my saved trials
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated:  11/13/2015
Vanderbilt Medical Center
mi
from
Nashville, TN
Maribavir for Treatment of Resistant or Refractory CMV Infections in Transplant Recipients
A Phase 2, Randomized Study to Assess the Safety and Anti-cytomegalovirus (CMV) Activity of Different Doses of Maribavir for Treatment of CMV Infections That Are Resistant or Refractory to Treatment With Ganciclovir/Valganciclovir or Foscarnet in Transplant Recipients
Status: Enrolling
Updated: 11/13/2015
Vanderbilt Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
Alamance Regional Medical Center
mi
from
Burlington, NC
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
Alamance Regional Medical Center
mi
from
Burlington, NC
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
University of North Carolina Hospitals
mi
from
Chapel Hill, NC
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
University of North Carolina Hospitals
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
Durham Regional Hospital
mi
from
Durham, NC
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
Durham Regional Hospital
mi
from
Durham, NC
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
Durham VA Medical Center
mi
from
Durham, NC
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
High Point Regional Health System
mi
from
High Point, NC
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
High Point Regional Health System
mi
from
High Point, NC
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
Rex Healthcare
mi
from
Raleigh, NC
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
Rex Healthcare
mi
from
Raleigh, NC
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
Duke Raleigh Hospital
mi
from
Raleigh, NC
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
Duke Raleigh Hospital
mi
from
Raleigh, NC
Click here to add this to my saved trials
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated:  11/15/2015
Chesapeake Regional Medical Center
mi
from
Chesapeake, VA
Effectiveness of Enhanced Terminal Room Disinfection to Prevent Healthcare-associated Infections (HAIs)
A Four-arm Prospective, Multicenter Study to Assess the Efficacy, Effectiveness, and Feasibility of Enhanced Terminal Room Disinfection With Chlorine and UV Light Using Clinical and Microbiologic Outcomes
Status: Enrolling
Updated: 11/15/2015
Chesapeake Regional Medical Center
mi
from
Chesapeake, VA
Click here to add this to my saved trials
Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
Pregnancy Outcomes Following Preconception Treatment of Asymptomatic Bacterial Vaginosis in an Infertility Population: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Status: Enrolling
Updated:  11/16/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Efficacy Study of Preconception Treatment of an Asymptomatic Bacterial Infection in an Infertility Population
Pregnancy Outcomes Following Preconception Treatment of Asymptomatic Bacterial Vaginosis in an Infertility Population: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial.
Status: Enrolling
Updated: 11/16/2015
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
PRO 140 by IV Administration in Adults With HIV-1 Infection
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of PRO 140 by Intravenous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection
Status: Enrolling
Updated:  11/16/2015
Progenics Pharmaceuticals, Inc.
mi
from
Tarrytown, NY
PRO 140 by IV Administration in Adults With HIV-1 Infection
A Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study of PRO 140 by Intravenous Administration in Adult Subjects With Human Immunodeficiency Virus Type 1 Infection
Status: Enrolling
Updated: 11/16/2015
Progenics Pharmaceuticals, Inc.
mi
from
Tarrytown, NY
Click here to add this to my saved trials
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Status: Enrolling
Updated:  11/16/2015
Boston Med Ctr
mi
from
Boston, MA
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Anal HPV Infection and Abnormal Cytology in HIV-infected Women
Status: Enrolling
Updated: 11/16/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes
Trial to Assess the Safety, Attenuation and Immunogenicity of Genetically-attenuated p52-/p36-/sap1- Plasmodium Falciparum Parasites (GAP3KO) Administered Via Infected Anopheles Stephensi Mosquitoes to Malaria-Naïve Adults
Status: Enrolling
Updated:  11/17/2015
Seattle Biomedical Research Institute Malaria Clinical Trial Center
mi
from
Seattle, WA
Safety, Attenuation and Immunogenicity of GAP3KO Administered Via A Stephensi Mosquitoes
Trial to Assess the Safety, Attenuation and Immunogenicity of Genetically-attenuated p52-/p36-/sap1- Plasmodium Falciparum Parasites (GAP3KO) Administered Via Infected Anopheles Stephensi Mosquitoes to Malaria-Naïve Adults
Status: Enrolling
Updated: 11/17/2015
Seattle Biomedical Research Institute Malaria Clinical Trial Center
mi
from
Seattle, WA
Click here to add this to my saved trials
A Pilot Study of Bevacizumab for Neoplastic Meningitis
A Pilot Study of Systemically Administered Bevacizumab in Patients With Neoplastic Meningitis (NM)
Status: Enrolling
Updated:  11/17/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
A Pilot Study of Bevacizumab for Neoplastic Meningitis
A Pilot Study of Systemically Administered Bevacizumab in Patients With Neoplastic Meningitis (NM)
Status: Enrolling
Updated: 11/17/2015
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Chula Vista, CA
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Chula Vista, CA
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Orlando, FL
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Carmel, IN
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Carmel, IN
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Hazard, KY
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Hazard, KY
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Springfield, MA
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Springfield, MA
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Detroit, MI
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Garden City, NY
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Garden City, NY
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Clinical Research Facility
mi
from
Bellaire, TX
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Clinical Research Facility
mi
from
Bellaire, TX
Click here to add this to my saved trials
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated:  11/18/2015
Research Site
mi
from
Cordoba,
Evaluation of Ceftaroline Fosamil Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Skin Infections
A Phase III, Multicentre, Randomised, Double-Blind Comparative Study to Evaluate the Efficacy and Safety of Ceftaroline Fosamil (600 mg Every 8 Hours) Versus Vancomycin Plus Aztreonam in the Treatment of Patients With Complicated Bacterial Skin and Soft Tissue Infections With Evidence of Systemic Inflammatory Response or Underlying Comorbidities
Status: Enrolling
Updated: 11/18/2015
Research Site
mi
from
Cordoba,
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Princeton Medical Center
mi
from
Birmingham, AL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Princeton Medical Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Decatur General Hospital
mi
from
Decatur, AL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Decatur General Hospital
mi
from
Decatur, AL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Eliza Coffee Memorial Hospital
mi
from
Florence, AL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Eliza Coffee Memorial Hospital
mi
from
Florence, AL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Riverview Regional Hospital
mi
from
Gadsden, AL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Riverview Regional Hospital
mi
from
Gadsden, AL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Community Memorial Hospital
mi
from
Ventura, CA
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Community Memorial Hospital
mi
from
Ventura, CA
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Watsonville Community Hospital
mi
from
Watsonville, CA
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Watsonville Community Hospital
mi
from
Watsonville, CA
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Citrus Memorial Hospital
mi
from
Inverness, FL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Citrus Memorial Hospital
mi
from
Inverness, FL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Osceola Regional Med Ctr
mi
from
Kissimmee, FL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Osceola Regional Med Ctr
mi
from
Kissimmee, FL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
University of Miami
mi
from
Miami, FL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Orlando Regional Hospital
mi
from
Orlando, FL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Orlando Regional Hospital
mi
from
Orlando, FL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Tallahassee Memorial Hospital
mi
from
Tallahassee, FL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Emory University Hospital
mi
from
Atlanta, GA
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Emory University Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Piedmont Medical Center
mi
from
Atlanta, GA
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Piedmont Medical Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Veteran's Administration Medical Center
mi
from
Atlanta, GA
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Veteran's Administration Medical Center
mi
from
Atlanta, GA
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Wellstar Kennestone Hospital
mi
from
Marietta, GA
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Wellstar Kennestone Hospital
mi
from
Marietta, GA
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Trinity Medical Center
mi
from
Rock Island, IL
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Trinity Medical Center
mi
from
Rock Island, IL
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
St. Mary's Medical
mi
from
Hobart, IN
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
St. Mary's Medical
mi
from
Hobart, IN
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Community Hospital, Munster
mi
from
Munster, IN
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Community Hospital, Munster
mi
from
Munster, IN
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
St. Margaret Mercy
mi
from
Munster, IN
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
St. Margaret Mercy
mi
from
Munster, IN
Click here to add this to my saved trials
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated:  11/20/2015
Johns Hopkins University Hospital
mi
from
Baltimore, MD
TYRX™ Envelope for Prevention of Infection Following Replacement With a CRT or ICD
Centurion and Citadel Studies of TYRX™ Anti-Bacterial Envelope and Custom Mesh for Prevention of Infection Following CIED Replacement With a CRT or ICD
Status: Enrolling
Updated: 11/20/2015
Johns Hopkins University Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials